Translate
About
Claritas Pharmaceuticals Inc (PINK:CLAZF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2022
Claritas Announces Approval from OTC to Up-List to OTCQB
Apr 5 2022
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
Jan 22 2021
BCSC-OSC Revocation of Cease Trade Order
Jul 14 2020
BCSC-OSC Partial Revocation of Cease Trade Order
Jun 22 2020
BCSC Cease Trade Order
Recent Videos
Technical Analysis of Kalytera (Claritas Pharmaceutical) (KALTD)
Aug 21, 2021
Financials
Revenue
$0
Market Cap
$4.37 K
P/E Ratio
0.00
EPS
0.90